A detailed history of Lpl Financial LLC transactions in Zomedica Corp. stock. As of the latest transaction made, Lpl Financial LLC holds 285,975 shares of ZOM stock, worth $37,176. This represents 0.0% of its overall portfolio holdings.

Number of Shares
285,975
Previous 282,878 1.09%
Holding current value
$37,176
Previous $42,000 4.76%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$0.12 - $0.16 $371 - $495
3,097 Added 1.09%
285,975 $40,000
Q2 2024

Aug 07, 2024

BUY
$0.12 - $0.18 $12,120 - $18,180
101,000 Added 55.53%
282,878 $42,000
Q1 2024

May 10, 2024

BUY
$0.12 - $0.19 $60 - $95
500 Added 0.28%
181,878 $27,000
Q4 2023

Feb 14, 2024

BUY
$0.15 - $0.22 $23,625 - $34,650
157,500 Added 659.6%
181,378 $36,000
Q3 2023

Nov 13, 2023

SELL
$0.16 - $0.23 $197 - $283
-1,232 Reduced 4.91%
23,878 $4,000
Q2 2023

Jul 31, 2023

BUY
$0.19 - $0.22 $735 - $851
3,872 Added 18.23%
25,110 $5,000
Q1 2023

May 10, 2023

SELL
$0.16 - $0.29 $5 - $10
-37 Reduced 0.17%
21,238 $4,000
Q4 2022

Feb 07, 2023

SELL
$0.16 - $0.25 $685 - $1,070
-4,283 Reduced 16.76%
21,275 $3,000
Q3 2022

Nov 14, 2022

BUY
$0.2 - $0.38 $100 - $190
500 Added 2.0%
25,558 $5,000
Q1 2022

May 16, 2022

SELL
$0.28 - $0.4 $3,527 - $5,039
-12,599 Reduced 33.46%
25,058 $8,000
Q4 2021

Feb 14, 2022

BUY
$0.31 - $0.58 $2,076 - $3,885
6,699 Added 21.64%
37,657 $12,000
Q3 2021

Nov 15, 2021

BUY
$0.46 - $0.81 $2,300 - $4,050
5,000 Added 19.26%
30,958 $16,000
Q2 2021

Aug 13, 2021

BUY
$0.72 - $1.46 $3,873 - $7,854
5,380 Added 26.14%
25,958 $22,000
Q1 2021

May 14, 2021

BUY
$0.35 - $2.7 $7,202 - $55,560
20,578 New
20,578 $33,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.